Search results
Author(s):
Robert-Jan van Geuns
,
Katherin Awad
,
Alexander IJsselmuiden
,
et al
Added:
3 years ago
Significant advances have been made with new generation stents to further improve the results of percutaneous coronary intervention (PCI) and outcomes for patients. Drug-eluting stents introduced in the early 2000s, thinner strut stent platforms, and bioabsorbable polymers and stents are among these developments.1 Despite these advances, there remain some areas where optimal stenting continues to…
View more
Clinical Impact of Stent Design
Author(s):
Rebecca L Noad
,
Colm Hanratty
,
Simon J Walsh
Added:
3 years ago
Article
Author(s):
Alfonso Ielasi
,
Alaide Chieffo
Added:
3 years ago
A critical stenosis in left main coronary artery (LMCA) is observed in 3–5% of all patients who undergo coronary angiography and in 10–30% of patients who undergo coronary artery bypass grafting (CABG).1 Significant LMCA disease is a high-risk condition because of the extent of jeopardised myocardium.
Current practice guidelines recommend CABG as the standard therapy for patients with…
View more
Author(s):
Ashok Seth
,
Sajal Gupta
,
Vivudh Pratap Singh
,
et al
Added:
3 years ago
In 1995, stent implantation became the second revolution in interventional cardiology when Colombo et al. demonstrated that intravascular ultrasound (IVUS)-guided post-dilatation of stents to achieve optimal expansion and larger lumens led to reduced restenosis and stent thrombosis (ST).1 This ‘bigger is better’ hypothesis became the technical cornerstone of all stent implantation in the bare…
View more
Author(s):
Niels Ramsing Holm
,
Evald Høj Christiansen
Added:
3 years ago
Optimal treatment of left main coronary artery (LMCA) lesions requires a highly tailored approach that incorporates patient comorbidities, clinical presentation, the extent of coronary artery disease (CAD), lesion characteristics and local expertise.1,2 Coronary artery bypass grafting (CABG) is the treatment for LMCA lesions that has the highest evidence level in guideline recommendations.2,3…
View more
Author(s):
Adrian P Banning
,
Giovanni Luigi De Maria
Added:
3 years ago
Introduction
Detecting obstructive disease of the left main coronary artery (LMCA) disease is a relatively unusual occurrence in the catheterisation laboratory, as it accounts for approximately 4 % of all coronary angiograms, with isolated LMCA disease observed in only 5–10 % of these cases.1 Historically, coronary artery bypass grafting (CABG) represented the treatment of choice with a well…
View more
Author(s):
Thierry Lefèvre
,
Yves Louvard
,
Marie-Claude Morice
Added:
3 years ago
Coronary bifurcation lesions with involvement of a significant side branch are a frequent occurrence. The Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) study showed that systematic use of drug-eluting stents (DES) resulted in an increase from 8% to 16% in the number of bifurcation lesions being stented over a one-year period. 1 This high incidence of coronary…
View more
Author(s):
Peter Barlis
,
Mun Hong Cheang
,
Carlo Di Mario
Added:
3 years ago
In the past few decades, tremendous developments have been made in the field of interventional cardiology. The evolution of such tools as balloon angioplasty, bare-metal stents (BMS) and now drug-eluting stents (DES) has incrementally opened up new possibilities in the treatment of coronary artery disease and, correspondingly, an ever-decreasing need for invasive surgery. The most challenging…
View more
Author(s):
Joanna J Wykrzykowska
,
Willem J van der Giessen
Added:
3 years ago
Approach to the Bifurcation Patient
Historically, bifurcation lesions have been associated with lower procedural success and a poorer clinical outcome than non-bifurcation lesions. This may be due to the technical difficulty of the procedure but also due to the complexity of the patients. According to the recently presented LEADERS trial sub-study,1 patients who have bifurcation disease are…
View more
Author(s):
Thierry Lefèvre
,
Yves Louvard
,
Marie-Claude Morice
Added:
3 years ago
Coronary bifurcation lesions with involvement of a significant side branch are a frequent occurrence. The Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) study showed that systematic use of drug-eluting stents (DES) resulted in an increase from 8% to 16% in the number of bifurcation lesions being stented over a one-year period. 1 This high incidence of coronary…
View more